{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:04:40Z","timestamp":1777374280365,"version":"3.51.4"},"reference-count":49,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T00:00:00Z","timestamp":1540339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["IP.07.31060.003"],"award-info":[{"award-number":["IP.07.31060.003"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:p>\n                    There is conflicting evidence of the impact of commonly used antiretroviral therapies (ARTs) on the pharmacokinetics of lumefantrine and the safety profile of artemether-lumefantrine. We compared the area under the concentration-time curve from 0 h to 14 days (AUC\n                    <jats:sub>0\u201314 days<\/jats:sub>\n                    ) of lumefantrine and the safety profile of artemether-lumefantrine in malaria-negative human immunodeficiency virus (HIV)-infected adults in two steps.\n                  <\/jats:p>","DOI":"10.1128\/aac.01162-18","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T08:59:09Z","timestamp":1535014749000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Efavirenz-, Ritonavir-Boosted Lopinavir-, and Nevirapine-Based Antiretroviral Regimens on the Pharmacokinetics of Lumefantrine and Safety of Artemether-Lumefantrine in Plasmodium falciparum-Negative HIV-Infected Malawian Adults Stabilized on Antiretroviral Therapy"],"prefix":"10.1128","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-5259","authenticated-orcid":false,"given":"Clifford G.","family":"Banda","sequence":"first","affiliation":[{"name":"University of Malawi, College of Medicine, Blantyre, Malawi"},{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fraction","family":"Dzinjalamala","sequence":"additional","affiliation":[{"name":"University of Malawi, College of Medicine, Blantyre, Malawi"},{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mavuto","family":"Mukaka","sequence":"additional","affiliation":[{"name":"University of Malawi, College of Medicine, Blantyre, Malawi"},{"name":"Oxford Centre for Tropical Medicine and Global Health, Oxford, United Kingdom"},{"name":"Mahidol-Oxford Tropical Medicine Research Unit, Bangkok, Thailand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Mallewa","sequence":"additional","affiliation":[{"name":"University of Malawi, College of Medicine, Blantyre, Malawi"},{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Maiden","sequence":"additional","affiliation":[{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianne J.","family":"Terlouw","sequence":"additional","affiliation":[{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi"},{"name":"Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Lalloo","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saye H.","family":"Khoo","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Mwapasa","sequence":"additional","affiliation":[{"name":"University of Malawi, College of Medicine, Blantyre, Malawi"},{"name":"Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/500245"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02727-6"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000247572.95880.92"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/498577"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1086\/507310"},{"key":"e_1_3_3_7_2","volume-title":"WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection","author":"WHO","year":"2017","unstructured":"WHO. 2017. WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. WHO, Geneva, Switzerland."},{"key":"e_1_3_3_8_2","volume-title":"WHO guidelines for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. 2015. WHO guidelines for the treatment of malaria, 3rd ed. WHO, Geneva, Switzerland.","edition":"3"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000174445.40379.e0"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-004-0855-8"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199936040-00004"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.1.3.473"},{"key":"e_1_3_3_13_2","volume-title":"Defining and defeating the intolerable burden of malaria III: progress and perspectives","author":"Breman J","year":"2007","unstructured":"Breman J, Alilio M, White NJ (ed). 2007. Defining and defeating the intolerable burden of malaria III: progress and perspectives. American Society of Tropical Medicine and Hygiene, Northbrook, IL."},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr596"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1345-1"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200501"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05265-11"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks207"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01153-15"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0695-2"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181acb4ff"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12529"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1080\/03602530902843483"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.12.007"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31826ebb5c"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0186589"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03430.x"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03136.x"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.104.003236"},{"key":"e_1_3_3_30_2","first-page":"41","volume-title":"The pharmacological basis of therapeutics","author":"Giacomini KM","year":"2005","unstructured":"Giacomini KM, Sugiyama Y. 2005. Membrane transporters and drug response, p 41\u201370. In Brunton LL, Lazo JS, Parker KL (ed), The pharmacological basis of therapeutics, 11th ed. McGraw-Hill, New York, NY.","edition":"11"},{"key":"e_1_3_3_31_2","first-page":"1","article-title":"Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose-insulin homeostasis in animal models","volume":"2","author":"Mastan SK","year":"2010","unstructured":"Mastan SK, Kumar KE. 2010. Effect of antiretroviral drugs on the pharmacodynamics of gliclazide with respect to glucose-insulin homeostasis in animal models. J Exp Pharmacol 2:1\u201311.","journal-title":"J Exp Pharmacol"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1086\/529192"},{"key":"e_1_3_3_33_2","volume-title":"Viramune (nevirapine) tablets & oral suspension","author":"Boehringer Ingelheim Pharmaceuticals Inc","year":"2005","unstructured":"Boehringer Ingelheim Pharmaceuticals Inc. 2005. Viramune (nevirapine) tablets & oral suspension. Boehringer Ingelheim Pharm Inc, Ridgefield, CT."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.4314\/mmj.v27i3.5"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2008.01.006"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-122"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199937020-00002"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.3.697-704.2000"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050253"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-5-59"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2008.05.022"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1086\/503423"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2006.01739.x"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2006.01785.x"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00830.x"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0456-7"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.8.1.75"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1542-474X.2003.08413.x"},{"key":"e_1_3_3_49_2","volume-title":"Division of AIDS table for grading the severity of adult and pediatric adverse events","author":"Division of AIDS, NIH","year":"2004","unstructured":"Division of AIDS, NIH. 2004. Division of AIDS table for grading the severity of adult and pediatric adverse events. Division of AIDS, NIAID, NIH, Bethesda, MD."},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-375"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01162-18","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01162-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:15:17Z","timestamp":1645460117000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01162-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1128\/AAC.01162-18"],"URL":"https:\/\/doi.org\/10.1128\/aac.01162-18","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/337410","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"2018-06-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01162-18"}}